The key question is if the small reduction in depression and anxiety potentially associated with RRM justifies the possible small decline in quality of life, body image satisfaction, and sexual well-being for the individual carrier of a P/LP variant in BRCA1/2 genes. The gene discussed is BRCA1; the disease is depressive symptom measurement.